Cargando…
Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer
Myeloid cell leukaemia-1 (Mcl-1) is an anti-apoptotic member of the Bcl-2 family that is elevated in a variety of tumour types including breast cancer. In breast tumours, increased Mcl-1 expression correlates with high tumour grade and poor patient survival. We have previously demonstrated that Her-...
Autores principales: | Booy, E P, Henson, E S, Gibson, S B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145838/ https://www.ncbi.nlm.nih.gov/pubmed/21258408 http://dx.doi.org/10.1038/onc.2010.616 |
Ejemplares similares
-
Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells
por: Schacter, Jennifer L., et al.
Publicado: (2014) -
Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
por: Goncharenko-Khaider, Nadzeya, et al.
Publicado: (2012) -
3-Chloroplumbagin Induces Cell Death in Breast Cancer Cells Through MAPK-Mediated Mcl-1 Inhibition
por: Kawiak, Anna, et al.
Publicado: (2019) -
BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
por: Li, Kun, et al.
Publicado: (2022) -
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
por: Henson, Elizabeth S, et al.
Publicado: (2007)